Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
27.75
-0.37 (-1.32%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Dianthus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Net Income
-56.68-43.56-28.48-13.11
Depreciation & Amortization
0.370.360.15-
Loss (Gain) From Sale of Investments
-1.8-1.42-0.61-
Stock-Based Compensation
7.042.91.520.06
Change in Accounts Receivable
-0.420.750.07-1.01
Change in Accounts Payable
2.640.662.284.92
Change in Unearned Revenue
-0.08-0.060.89-
Change in Other Net Operating Assets
-2.423.5-4.89-0.77
Operating Cash Flow
-51.32-36.86-29.07-9.9
Capital Expenditures
-0.12-0.11-0.14-0.03
Investment in Securities
-23.9620.36-59.68-
Investing Cash Flow
-24.0820.25-59.82-0.03
Short-Term Debt Issued
-0.38--
Total Debt Issued
-0.38--
Short-Term Debt Repaid
--0.38--
Total Debt Repaid
--0.38--
Issuance of Common Stock
230.320.01--
Other Financing Activities
118.9133.57-3.32-0.09
Financing Cash Flow
349.23133.5796.6814.91
Net Cash Flow
273.83116.977.794.98
Free Cash Flow
-51.44-36.97-29.21-9.94
Free Cash Flow Margin
-1249.13%-1308.24%-455.18%-673.24%
Free Cash Flow Per Share
-2.50-7.17-33.41-2.48
Levered Free Cash Flow
-35.12-22.81-19.31-
Unlevered Free Cash Flow
-35.12-22.81-19.31-
Change in Net Working Capital
-0.57-4.152.27-
Source: S&P Capital IQ. Standard template. Financial Sources.